Home

Insights

PE

Chemo Pharma Laboratories Ltd P/E Ratio

Chemo Pharma Laboratories Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

0.4 K

stocks traded

Last Updated time: 12 Jul 15:30 PM

Image

Chemo Pharma Laboratories Ltd

NSE: CHEMOPHARMALAB

PE

7.5

Last updated : 12 Jul 15:30 PM

Key Highlights

    The P/E Ratio of Chemo Pharma Laboratories Ltd is 7.5 as of 12 Jul 15:30 PM .a1#The P/E Ratio of Chemo Pharma Laboratories Ltd changed from 7.7 on March 2019 to 124.7 on March 2023 . This represents a CAGR of 74.53% over 5 years. a1#The Latest Trading Price of Chemo Pharma Laboratories Ltd is ₹ 60.13 as of 12 Jul 15:30 .a1#The PE Ratio of Pharmaceuticals Industry has changed from 28.5 to 27.2 in 5 years. This represents a CAGR of -0.93%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.3. The PE Ratio of Pharmaceuticals industry is 37.3. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Chemo Pharma Laboratories Ltd changed from ₹ 1.59 crore on March 2019 to ₹ 5.99 crore on March 2023 . This represents a CAGR of 30.38% over 5 years. a1#The Revenue of Chemo Pharma Laboratories Ltd changed from ₹ -0.38 crore to ₹ 0.25 crore over 8 quarters. This represents a CAGR of NaN% a1#The EBITDA of Chemo Pharma Laboratories Ltd changed from ₹ -0.5 crore to ₹ 0.15 crore over 8 quarters. This represents a CAGR of NaN% a1#The Net Pr of Chemo Pharma Laboratories Ltd changed from ₹ -0.5 crore to ₹ -0.29 crore over 8 quarters. This represents a CAGR of -23.84% a1#The Dividend Payout of Chemo Pharma Laboratories Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Chemo Pharma Laboratories Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Chemo Pharma Laboratories Ltd

Period
Mar '197.7
Mar '202.3
Mar '2110.7
Mar '2211.1
Mar '23124.7

Company Fundamentals for Chemo Pharma Laboratories Ltd

Market Cap

9 Cr

EPS

8.0

P/E Ratio (TTM) *

7.5

P/B Ratio (TTM) *

0.7

Day’s High

61.93

Day’s Low

60.07

DTE *

0.0

ROE *

9.4

52 Week High

87.0

52 Week Low

27.17

ROCE *

12.8

* All values are consolidated

Last Updated time: 12 Jul 15:30 PM

* All values are consolidated

Last Updated time: 12 Jul 15:30 PM

Image

Chemo Pharma Laboratories Ltd

NSE: CHEMOPHARMALAB

PRICE

60.13

1.14 (1.93%)

stock direction

Last updated : 12 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

SWOT Analysis Of Chemo Pharma Laboratories Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

Asset Value vs Market Value of Chemo Pharma Laboratories Ltd

Market Value

9

Asset Value

6

0.4 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Chemo Pharma Laboratories Ltd79
Sun Pharmaceuticals Industries Ltd37378,675
Cipla Ltd28122,093
Divis Laboratories Ltd75120,480
Zydus Lifesciences Ltd30118,217
Dr Reddys Laboratories Ltd20112,137

Key Valuation Metric of Chemo Pharma Laboratories Ltd

Earnings

1 Cr

7.5 X

PE Ratio

Market Cap

₹9.02Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

1 Cr

7.5 X

PE Ratio

Market Cap

₹9.02Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Chemo Pharma Laboratories Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Chemo Pharma Laboratories Ltd

Period
Mar '192
Mar '201
Mar '213
Mar '226
Mar '236

* All values are a in crore

×

Historical Revenue of Chemo Pharma Laboratories Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Chemo Pharma Laboratories Ltd

Period
Jun '220
Sep '221
Dec '220
Mar '230
Jun '230
Sep '230
Dec '231
Mar '240

* All values are a in crore

×

Historical EBITDA of Chemo Pharma Laboratories Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Chemo Pharma Laboratories Ltd

Period
Jun '220
Sep '221
Dec '220
Mar '230
Jun '230
Sep '230
Dec '231
Mar '240

* All values are a in crore

×

Historical Net Profit of Chemo Pharma Laboratories Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Chemo Pharma Laboratories Ltd

Period
Jun '220
Sep '221
Dec '220
Mar '230
Jun '230
Sep '230
Dec '231
Mar '240

* All values are a in crore

×

Historical Dividend Payout of Chemo Pharma Laboratories Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Chemo Pharma Laboratories Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Chemo Pharma Laboratories Ltd

About Chemo Pharma Laboratories Ltd

    Chemo Pharma Laboratories Limited was established in August, 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs, the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource, with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.

Chemo Pharma Laboratories Ltd News Hub

News

Chemo Pharma Laboratories to convene board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

10 Jul 202409:29

News

Chemo Pharma Laboratories to convene board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

10 May 202416:22

News

Chemo Pharma Laboratories to hold board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

09 Jan 202419:42

News

Chemo Pharma Laboratories schedules board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

16 Oct 202314:22

News

Chemo Pharma Laboratories to conduct AGM

Chemo Pharma Laboratories announced that the 81th Annual General Meeting (AGM) of the comp...

Read more

28 Jul 202317:25

News

Chemo Pharma Laboratories to conduct board meeting

Chemo Pharma Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

15 Jul 202309:44

Product Composition by Percentage (Revenue)

FAQs for PE of Chemo Pharma Laboratories Ltd

What is Chemo Pharma Laboratories Ltd current share price?

The current market price of Chemo Pharma Laboratories Ltd as of July 12, 2024 is ₹60.13.

What is Chemo Pharma Laboratories Ltd's market cap?

Chemo Pharma Laboratories Ltd's market capitalisation stood at ₹9 Cr as of July 12, 2024

What are Chemo Pharma Laboratories Ltd's total net assets?

According to Chemo Pharma Laboratories Ltd's most recent financial filings, the company's net assets total ₹6.4 Cr.

Is Chemo Pharma Laboratories Ltd making a profit or loss?

Chemo Pharma Laboratories Ltd's net Profit as of July 12, 2024 is close to ₹1 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199